Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis
- PMID: 21173657
- DOI: 10.1097/AOG.0b013e318202b0a4
Increased risk for abnormal depression scores in women with polycystic ovary syndrome: a systematic review and meta-analysis
Abstract
Objective: Polycystic ovary syndrome (PCOS) and depression both have a high prevalence in reproductive-aged women. This study aimed to determine the prevalence of abnormal depression scores in women who meet currently recognized definitions of PCOS compared with women in a well-defined control group.
Data sources: The search was performed in MEDLINE, EMBASE Classic plus EMBASE, PsycINFO, Current Contents-Clinical Medicine and Current Contents-Life Sciences and Web of Science. Cochrane software Review Manager 5.0.24 was used to construct forest plots comparing risk of abnormal depression scores in those in the PCOS and control groups.
Methods of study selection: Studies with well-defined criteria of women with PCOS and control groups of women without PCOS, with demographic information including age and body mass index (BMI), were included. Of 752 screened articles, 17 met the selection criteria for systematic review and 10 studies were included in the meta-analysis.
Tabulation, integration, and results: Data were abstracted independently by three reviewers. All studies were cross-sectional and most used the Rotterdam criteria for the diagnosis of PCOS (n=10). The odds ratio (OR) for abnormal depression scores was 4.03 (95% confidence interval [CI] 2.96-5.5, P<.01) in women with PCOS (n=522) compared with those in the control groups (n=475). A subanalysis showed that the odds for abnormal depression scores was independent of BMI (OR 4.09, 95% CI 2.62-6.41). Several validated tools were used to screen for depression; the common tool used was the Beck Depression Inventory.
Conclusion: The results of our study suggest the need to screen all women with PCOS for depression using validated screening tools. Women with PCOS are at an increased risk for abnormal depression scores independent of BMI.
Comment in
-
Defining risk in women with polycystic ovary syndrome: a need for constant vigilance.Obstet Gynecol. 2011 Jan;117(1):1-2. doi: 10.1097/AOG.0b013e318202f06c. Obstet Gynecol. 2011. PMID: 21173638 No abstract available.
Similar articles
-
High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome: a systematic review and meta-analysis.Hum Reprod. 2017 May 1;32(5):1075-1091. doi: 10.1093/humrep/dex044. Hum Reprod. 2017. PMID: 28333286 Review.
-
Increased prevalence of anxiety symptoms in women with polycystic ovary syndrome: systematic review and meta-analysis.Fertil Steril. 2012 Jan;97(1):225-30.e2. doi: 10.1016/j.fertnstert.2011.10.022. Epub 2011 Nov 27. Fertil Steril. 2012. PMID: 22127370 Review.
-
Psychiatric disorders in women with polycystic ovary syndrome: a systematic review and meta-analysis.Endocrine. 2018 Nov;62(2):318-325. doi: 10.1007/s12020-018-1692-3. Epub 2018 Jul 31. Endocrine. 2018. PMID: 30066285 Review.
-
Direct economic burden of mental health disorders associated with polycystic ovary syndrome: Systematic review and meta-analysis.Elife. 2023 Aug 3;12:e85338. doi: 10.7554/eLife.85338. Elife. 2023. PMID: 37534878 Free PMC article.
-
Putative role for insulin resistance in depression risk in polycystic ovary syndrome.Fertil Steril. 2015 Sep;104(3):707-14.e1. doi: 10.1016/j.fertnstert.2015.05.019. Epub 2015 Jun 19. Fertil Steril. 2015. PMID: 26054555
Cited by
-
Developing a Novel Web-Based Self-Management Support Intervention for Polycystic Ovary Syndrome: Mixed Methods Study With Patients and Health Care Professionals.JMIR Form Res. 2024 Mar 7;8:e52427. doi: 10.2196/52427. JMIR Form Res. 2024. PMID: 38451567 Free PMC article.
-
Anxiety, depression, and body image among infertile women with and without polycystic ovary syndrome.Hum Reprod. 2024 Apr 3;39(4):784-791. doi: 10.1093/humrep/deae016. Hum Reprod. 2024. PMID: 38335234 Free PMC article.
-
Type and Frequency in Use of Nutraceutical and Micronutrient Supplementation for the Management of Polycystic Ovary Syndrome: A Systematic Scoping Review.Biomedicines. 2023 Dec 18;11(12):3349. doi: 10.3390/biomedicines11123349. Biomedicines. 2023. PMID: 38137570 Free PMC article. Review.
-
Sex and Sleep Disruption as Contributing Factors in Alzheimer's Disease.J Alzheimers Dis. 2024;97(1):31-74. doi: 10.3233/JAD-230527. J Alzheimers Dis. 2024. PMID: 38007653 Free PMC article. Review.
-
Depression in Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.J Clin Med. 2023 Oct 10;12(20):6446. doi: 10.3390/jcm12206446. J Clin Med. 2023. PMID: 37892583 Free PMC article. Review.
References
-
- Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745–9.
-
- Asuncion M, Calvo RM, San Millan JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434–8.
-
- Dokras A, Bochner M, Hollinrake E, Markham S, Vanvoorhis B, Jagasia DH. Screening women with polycystic ovary syndrome for metabolic syndrome. Obstet Gynecol 2005;106:131–7.
-
- Ehrmann D, Barnes R, Rosenfield R, Cavaghan M, Imperial J. Prevalence and predictors of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22:141–6.
-
- Wild RA, Painter PC, Coulson PB, Carruth KB, Ranney GB. Lipoprotein lipid concentrations and cardiovascular risk in women with polycystic ovary syndrome. J Clin Endocrinol Metab 1985;61:946–51.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous